Cite
MLA Citation
Johannes Weller et al.. “BIOM-08. DNA METHYLATION-BASED SUBGROUPING PREDICTS SURVIVAL BENEFIT FROM LOMUSTINE/TEMOZOLOMID COMBINATION THERAPY IN MGMT PROMOTOR-METHYLATED GLIOBLASTOMA.” Neuro-oncology, vol. 23, 2021, p. vi11. http://access.bl.uk/ark:/81055/vdc_100146089652.0x00000f